Skip to main content

Cancer drug listing

Find detailed information for nearly 200 cancer drugs, including brand and generic names for each drug, what it is intended to treat, how it is administered, and possible side effects.

To find out if a Food and Drug Administration-approved drug is in short supply, visit the FDA website.

Showing results for:

6-Thioguanine

Drug name(s)

Tabloid® Thioguanine 6-Thioguanine

Approved for

  • Leukemia

Arsenic trioxide

Drug name(s)

Trisenox® Arsenic trioxide

Approved for

  • Leukemia
  • Acute promyelocytic leukemia (APL)

Bendamustine hydrochloride

Drug name(s)

Treanda® Bendamustine hydrochloride Bendeka™

Approved for

  • Lymphoma

Bexarotene

Drug name(s)

Targretin® Bexarotene

Approved for

  • Lymphoma
  • Cutaneous T-cell Lymphoma (CTCL)
  • Other Blood Cancers

Brexucabtagene autoleucel

Drug name(s)

Tecartus® Brexucabtagene autoleucel

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)
  • Lymphoma
  • Mantle Cell Lymphoma (MCL) 

Etoposide

Drug name(s)

Etopophos® Toposar® VePesid® VP-16 Etoposide

Approved for

  • Lymphoma
  • Hodgkin Lymphoma (HL)
  • Non-Hodgkin Lymphoma (NHL)

Ivosidenib

Drug name(s)

Tibsovo® Ivosidenib

Approved for

  • Leukemia
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)

Methotrexate

Drug name(s)

Rheumatrex® Trexall® Methotrexate

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)
  • Non-Hodgkin Lymphoma (NHL)
  • Other Blood Cancers

Nilotinib

Drug name(s)

Tasigna® Danziten Cavhanza Nilotinib

Approved for

  • Leukemia
  • Chronic Myeloid Leukemia (CML)

Rituximab

Drug name(s)

Rituxan® Rituximab Truxima® * Rituximab-abbs* Ruxience™ * Rituximab-pvvr* Riabni Rituximab-arrx*

Approved for

  • Leukemia
  • Chronic Lymphocytic Leukemia (CLL/SLL)
  • B-Cell Prolymphocytic Leukemia
  • Lymphoma
  • Non-Hodgkin Lymphoma (NHL)
  • Burkitt Lymphoma (BL)
  • Diffuse Large B-cell Lymphoma (DLBCL) 

Tafasitamab-cxix

Drug name(s)

Monjuvi® Tafasitamab-cxix

Approved for

  • Lymphoma
  • Diffuse Large B-cell Lymphoma (DLBCL) 

Tagraxofusp-erzs

Drug name(s)

Elzonris™ Tagraxofusp-erzs

Approved for

  • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Talquetamab-tgvs

Drug name(s)

Talquetamab-tgvs Talvey™

Approved for

  • Myeloma

Teclistamab-cqyv

Drug name(s)

Tecvayli™ Teclistamab-cqyv

Approved for

  • Myeloma

Teniposide

Drug name(s)

Vumon® VM-26 Teniposide

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)
  • Lymphoma
  • Non-Hodgkin Lymphoma (NHL)
  • Other Blood Cancers

Thalidomide

Drug name(s)

Thalomid® Thalidomide

Approved for

  • Myeloma
  • Myelodysplastic Syndromes (MDS)

Tisagenlecleucel

Drug name(s)

Kymriah® Tisagenlecleucel

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)
  • Lymphoma
  • Diffuse Large B-cell Lymphoma (DLBCL) 
  • Follicular Lymphoma (FL) 

Tocilizumab

Drug name(s)

Actemra® Tocilizumab

Approved for

  • Other Blood Cancers

Topotecan

Drug name(s)

Hycamtin® Topotecan

Approved for

  • Leukemia
  • Acute Lymphoblastic Leukemia (ALL)
  • Acute Myeloid Leukemia (AML)

Tretinoin

Drug name(s)

Vesanoid® ATRA Tretinoin All-trans retinoic acid (ATRA)

Approved for

  • Leukemia
  • Acute Myeloid Leukemia (AML)
  • Acute promyelocytic leukemia (APL)

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.